Top Qs
Timeline
Chat
Perspective

Carteolol

Chemical compound From Wikipedia, the free encyclopedia

Carteolol
Remove ads

Carteolol is a non-selective beta blocker used to treat glaucoma. It is administered in the form of eye drops.[citation needed]

Quick facts Clinical data, Trade names ...

Carteolol was patented in 1972 and approved for medical use in 1980.[1]

Remove ads

Pharmacology

Pharmacodynamics

Carteolol is a beta blocker, or an antagonist of the β-adrenergic receptors.[2] It is selective for the β1-adrenergic receptor and has intrinsic sympathomimetic activity.[2] Carteolol has also been found to act as a serotonin 5-HT1A and 5-HT1B receptor antagonist in addition to being a beta blocker.[3]

Pharmacokinetics

Carteolol is classified as a beta blocker with low lipophilicity and hence lower potential for crossing the blood–brain barrier.[2] This in turn may result in fewer effects in the central nervous system as well as a lower risk of neuropsychiatric side effects.[2]

Remove ads

Chemistry

The experimental log P of carteolol is 1.1 and its predicted log P ranges from 0.99 to 2.39.[4][5][6][7] It is a hydrophilic or low-lipophilicity beta blocker.[7][2]

Society and culture

Brand names

Brand names of carteolol include Arteolol, Arteoptic, Calte, Cartéabak, Carteol, Cartéol, Cartrol, Elebloc, Endak, Glauteolol, Mikelan, Ocupress, Poenglaucol, Singlauc, and Teoptic.

References

Further reading

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads